ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,434.70
0.17%
Dow Jones
40,003.59
0.00%
Gold vs US Dollar
2,427.795
0.34%
Brent Oil
83.385
-0.25%
Bitcoin
67,073.75
1.38%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enochian Biosciences Inc (ENOB)

  7. Enochian Biosciences Inc (ENOB) News

Enochian Biosciences (ENOB)

Enochian Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENOB
DateTimeSourceHeadlineSymbolCompany
30/04/202421:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
24/04/202422:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
08/04/202422:44Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
19/03/202415:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
13/03/202419:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
13/03/202419:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
13/03/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
16/02/202423:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
16/02/202420:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
16/02/202414:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202414:38Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
16/02/202414:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202414:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202413:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
15/02/202423:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
14/02/202422:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENOBEnochian Biosciences Inc
14/02/202421:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
07/02/202421:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
25/01/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:06Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/01/202421:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
16/01/202422:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENOBEnochian Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENOB

Your Recent History

NYSE
KSS
Kohls
ASX
STOCD
Santos
LSE
VMUK
Virgin Money Uk
NASDAQ
MWK
Mohawk
LSE
34YC
Assa 23
BOV
P1KX34M
POSCO
NYSE
HHC
Howard Hughes
NASDAQ
FBQSPX
Dividend Growth Portfoli...
LSE
RTHM
USOTC
CUBV
CUBA Beverage (PK)
NYSE
BST
BlackRock Science and Te...
BOV
CTNM4
COTEMINAS PN
NYSE
TRNO
Terreno Realty
LSE
0IPT
Akastor Asa
COIN
PEARLUST
PEARL
BIT
RCS
Rizzoli Corriere della S...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved